Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No significant changes were detected in the study record between the screenshots; the core content (title, conditions, interventions, eligibility criteria, outcomes, and locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T13:43:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Important updates include a notice about government funding impacts and operating status, plus a new version (v3.2.0); the old version tag (v3.1.0) was removed. If no other major content changes are present, this represents an operational update rather than a broad content overhaul.
    Difference
    2%
    Check dated 2025-10-06T04:23:20.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Core terminology updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and the document/page version bumped to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T23:38:52.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page revision is updated from v3.0.1 to v3.0.2, signaling a new release; the 'Back to Top' link was removed, a minor UX change.
    Difference
    0.1%
    Check dated 2025-09-14T10:03:49.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T07:57:58.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, as well as a revision of medical terms related to renal carcinoma and immunological agents.
    Difference
    5%
    Check dated 2025-08-31T01:05:48.000Z thumbnail image

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.